Skip to main content

Table 2 Lung lesion scores in trivalent vaccine mixture and respective monovalent vaccines

From: Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge

Groups

Macroscopic

Microscopic

Lung lesion score

Mycoplasmal lesion score

Interstitial lesion score

Vac3FLEX/Ch3

9 ± 4.47 bc

0.6 ± 0.68 b

0.9 ± 0.64 b

VacMhp/ChMhp

5.75 ± 4.94 cd

0.4 ± 0.50 bc

0.1 ± 0.31 c

UnVac/Ch3

42 ± 11.11 a

3.5 ± 0.71 a

3.3 ± 0.82 a

UnVac/ChMhp

12.5 ± 6.35 b

3.1 ± 0.74 a

0.2 ± 0.42 c

UnVac/UnCh

0.5 ± 1.58 d

0 c

0.1 ± 0.32 c

Vac3FLEX/Ch3

9 ± 4.47 b

0.6 ± 0.68 b

0.9 ± 0.64 b

VacPCV2/ChPCV2

1.75 ± 2.45 c

0.05 ± 0.22 c

0.1 ± 0.31 c

UnVac/Ch3

42 ± 11.11 a

3.5 ± 0.71 a

3.3 ± 0.82 a

UnVac/ChPCV2

4.5 ± 3.69 bc

0.2 ± 0.42 bc

0.9 ± 0.57 b

UnVac/UnCh

0.5 ± 1.58 c

0 c

0.1 ± 0.32 c

Vac3FLEX/Ch3

9 ± 4.47 bc

0.6 ± 0.68 b

0.9 ± 0.64 c

VacPRRS/ChPRRSV

4.7 ± 3.36 cd

0.1 ± 0.31 c

0.25 ± 0.44 d

UnVac/Ch3

42 ± 11.11 a

3.5 ± 0.71 a

3.3 ± 0.82 a

UnVac/ChPRRSV

11.5 ± 6.69 b

0.1 ± 0.32 bc

1.5 ± 0.53 b

UnVac/UnCh

0.5 ± 1.58 d

0 c

0.1 ± 0.32 d

  1. Different letters mean statistically significant differences within 5 groups (P < 0.05)
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us